Evidence map›Paper›PMID 26272408›Full record

ReviewNature reviews. Microbiology2015

Staphylococcal manipulation of host immune responses.

Vilasack Thammavongsa, Hwan Keun Kim, Dominique Missiakas, Olaf Schneewind

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 371 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
371citing papers in PubMed, 1 pooled it
30.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

371 citing papers in PubMed, 1 synthesis or guideline pooled it, 581 citations in OpenAlex.

  1. The evolving landscape ofFrontiers in immunology · 2026
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Staphylococcus aureus-vascular endothelium interactions: Mechanisms and therapeutic opportunities.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Phylogenetic Analysis and Structural Evaluation ofbioRxiv : the preprint server for biology · 2026
    Article
  18. Virulence Profiling of Multidrug-Resistant ClinicalMicrobial drug resistance (Larchmont, N.Y.) · 2026
    Article
  19. Article
  20. Article

311 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vilasack Thammavongsa1] Department of Microbiology, University of Chicago, 920 East 58th Street, Chicago, Illinois 60637, USA. [2] Regeneron Pharmaceuticals, 755 Old Saw Mill River Road, Tarrytown, New York 10591, USA.
Hwan Keun KimDepartment of Microbiology, University of Chicago, 920 East 58th Street, Chicago, Illinois 60637, USA.
Dominique MissiakasDepartment of Microbiology, University of Chicago, 920 East 58th Street, Chicago, Illinois 60637, USA.
Olaf SchneewindDepartment of Microbiology, University of Chicago, 920 East 58th Street, Chicago, Illinois 60637, USA.
University of Chicago · US

Funding

Surface Proteins of Gram-Positive BacteriaR01AI038897 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 1996 to 2024
$8.9M
Vaccine Assembly from Surface Proteins of Staphylococcus AureusR01AI052474 · NIAID · UNIVERSITY OF CHICAGO · PI Dominique Missiakas · 2002 to 2026
$8.8M
Molecular basis and intervention of Staphylococcus aureus agglutinationR01AI110937 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 2015 to 2019
$1.8M
Molecular basis and intervention of Staphylococcus aureus agglutinationR56AI110937 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 2014 to 2014
$389k
Prototype Fabrication of a Cell Migration SensorR41AI052747 · NIAID · RAINMAKER TECHNOLOGY, INC. · PI SALDIVAR, ENRIQUE · 2002 to 2002
$122k
NIAID NIH HHS AI038897NIAID NIH HHS AI052747NIAID NIH HHS AI110937NIAID NIH HHS R01 AI038897NIAID NIH HHS R01 AI052474NIAID NIH HHS R01 AI110937NIAID NIH HHS R56 AI110937
6 · The paper itself

Abstract

Staphylococcus aureus, a bacterial commensal of the human nares and skin, is a frequent cause of soft tissue and bloodstream infections. A hallmark of staphylococcal infections is their frequent recurrence, even when treated with antibiotics and surgical intervention, which demonstrates the bacterium's ability to manipulate innate and adaptive immune responses. In this Review, we highlight how S. aureus virulence factors inhibit complement activation, block and destroy phagocytic cells and modify host B cell and T cell responses, and we discuss how these insights might be useful for the development of novel therapies against infections with antibiotic resistant strains such as methicillin-resistant S. aureus.

Indexed as

AgglutinationComplement ActivationGene Expression Regulation, BacterialHumansImmune EvasionLymphocyte ActivationPhagocytosisStaphylococcal InfectionsStaphylococcus aureusVirulence FactorsVirulence Factors

Identifiers

PMID26272408
PMCPMC4625792
OpenAlexW2218183054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.